Erectile Dysfunction Drugs Tied to Less Alzheimer’s Risk
Erectile dysfunction drugs were associated with reduced risk of Alzheimer’s disease, electronic health record (EHR) data from 270,000 men in the U.K. suggested. Over a median follow-up of about 5 years, men who started taking phosphodiesterase type 5 (PDE5) inhibitors were less likely to have an Alzheimer’s diagnosis than nonusers (adjusted HR 0.82, 95% CI […]
Erectile Dysfunction Drugs May Have Major Cardiovascular Benefits
CHICAGO — The two most popular medications for erectile dysfunction (ED) may confer substantial cardiovascular benefits for men with ED and concurrent heart disease, according to an analysis of a health research database. Both sildenafil and tadalafil significantly reduced the likelihood of progression to heart failure, myocardial infarction (MI), and death after 5 years as […]
ED Meds Linked to Higher Risk of Ocular Adverse Events
Regular users of common medications for erectile dysfunction (ED) are at a higher risk for ocular adverse events, according to a large cohort study. Among over 200,000 men using phosphodiesterase type 5 inhibitors (PDE5Is), the adjusted incidence rate ratio (IRR) for the composite endpoint of serous retinal detachment (SRD), retinal vascular occlusion (RVO), and ischemic […]